CLOV — Clover Health Investments Cashflow Statement
0.000.00%
Last trade - 00:00- $314.81m
- $16.49m
- $2.03bn
- 30
- 62
- 53
- 47
Annual cashflow statement for Clover Health Investments, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.018 | -6.74 | -588 | -340 | -213 |
| Depreciation | |||||
| Non-Cash Items | — | -0.117 | 112 | 130 | 158 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | 4.63 | 193 | -77.6 | -62.7 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.018 | -2.23 | -282 | -286 | -116 |
| Capital Expenditures | — | — | -0.723 | -4.47 | -0.584 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -828 | -435 | 99.6 | 141 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | -828 | -435 | 95.1 | 140 |
| Financing Cash Flow Items | 0.018 | -0.776 | 666 | 82.4 | -28.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.018 | 858 | 925 | 77.5 | -33.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 28 | 208 | -114 | -9.72 |